"Through our world-class team and collaboration partners, we are building a health science company that seeks to improve the lives of people suffering from chronic diseases,” Dr. Brian Curry, CEO of PhysioGenix.

We work as an integral part of our client’s drug and medical device development process. Our preclinical in vivo services include efficacy, pharmacodynamics, pharmacokinetics, and behavioral analysis. We also offer bioanalytical, laboratory, and surgical services. We focus on complex chronic diseases: diabetes, metabolic disorders, cardiovascular disease, and neurological disorders.

We have worked with 8 of the top 20 biopharmaceutical companies and numerous mid-size and early-stage biopharmaceutical companies to develop customized research programs. Our active participation and frequent communication with our clients has led to long-term ongoing relationships.

We retain world-leading experts in complex chronic diseases to provide you with high-impact solutions. We use a variety of standard research models. However, when appropriate we couple our experienced human capital with our proprietary research models to mimic disease progression seen in humans to more accurately translate preclinical results into clinical success. The data we collect from your studies is delivered on a real-time basis, allowing for agile study re-composition when necessary.